Home/Filings/4/0001731122-22-001013
4//SEC Filing

Skarpelos Athanasios 4

Accession 0001731122-22-001013

CIK 0001314052other

Filed

May 26, 8:00 PM ET

Accepted

May 27, 8:30 PM ET

Size

8.3 KB

Accession

0001731122-22-001013

Insider Transaction Report

Form 4
Period: 2022-05-25
Transactions
  • Exercise/Conversion

    Common Stock

    2022-05-25$0.92/sh+50,000$46,0001,356,458 total
  • Sale

    Common Stock

    2022-05-25$9.06/sh50,000$453,0001,306,458 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2022-05-25+50,0000 total
    Exercise: $0.92Exp: 2025-04-02Common Stock (50,000 underlying)
Footnotes (1)
  • [F1]The options subject to this grant vested quarterly over a three-year period commencing on April 2, 2015.

Documents

1 file

Issuer

ANAVEX LIFE SCIENCES CORP.

CIK 0001314052

Entity typeother

Related Parties

1
  • filerCIK 0001360570

Filing Metadata

Form type
4
Filed
May 26, 8:00 PM ET
Accepted
May 27, 8:30 PM ET
Size
8.3 KB